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from that of PKC- e and PKC-a. An important methodologicalRegulation of protein kinase C-d and - e isoforms by phorbol
finding is that one given antibody may not recognize all phos-ester treatment of LLC-PK1 renal epithelia.
phoproteins of a given PKC isoform.Background. LLC-PK1 renal epithelia are a widely used
model for proximal tubular physiology and differentiation. Pro-
tein kinase C (PKC) has been observed to play a role in both
processes. This study examines the subcellular distribution and
Protein kinase C (PKC) is a family of phospholipid-down-regulation of PKC-d and PKC- e isoforms in phorbol
dependent protein kinases consisting of at least 10 differ-ester-treated LLC-PK1 epithelia.
Methods. Cells were treated with 1027 mol/L 12-O-tetradec- ent isoforms encoded by separate genes. These isoforms
anoyl phorbol 13-acetate (TPA) for up to seven days and were can be classified into three groups—classic (cPKC), new
extracted as total cell lysates as well as cytosolic, membrane- (nPKC), and atypical (aPKC)—based on the structures
associated (Triton-X soluble) and a third (Triton-X insoluble)
of their regulatory domains [1, 2]. All show distinct enzy-fraction. The expression and cellular localization of PKC-d and
mological properties, differential tissue distribution, andPKC-e isoforms were then detected using Western immunoblot
and immunofluorescence. specific subcellular localization with distinct modes of
Results. Based on the use of an anti-PKC-d monoclonal anti- cellular regulation [3–5]. These differences in structure,
body, TPA was observed to cause a rapid decrease in total enzymatic properties and intracellular localization stronglyPKC-d content, which then returned to near control levels by
suggest specific functions for each of the isoforms of PKC;seven days of treatment. Immunofluorescence indicated that
however, these have not yet been clearly defined, norPKC-d had a cytoskeletal localization within the cells, and a
subtle cytoskeletal rearrangement occurred upon exposure to have unique target proteins been identified.
TPA. Western immunoblots showed that PKC-d did not un- These isoforms of the PKC family are the major recep-
dergo the expected membrane translocation upon activation tors for the tumor-promoting phorbol esters and are there-by TPA, but simply disappeared immediately from the cytosolic
fore thought to play an important role not only in generalcompartment. Conventional cell fractionation procedures such
signal transduction, but also in carcinogenesis. PKC isas homogenization and Triton extraction prior to Western im-
munoblot will, however, fail to evaluate completely PKC-d in normally activated by diacylglycerol (DAG) produced by
LLC-PK1 epithelia because of the highly stringent measures the receptor-coupled hydrolysis of membrane phospho-
necessary to extract PKC-d from the cytoskeletal compartment
inositides [6]. Phorbol esters such as 12-O-tetradecanoylof these cells. Furthermore, we observed that a second (poly-
phorbol 13-acetate (TPA) bind to the DAG binding siteclonal) PKC-d antibody may recognize phosphorylated forms
of PKC-d, which went unrecognized by the other antibody. of the regulatory domain of all but the atypical PKCs
PKC-e was present in the cytosol, membrane, and Triton-X– and activate their catalytic activity [2]. The fact that phor-
insoluble fractions of the cells. TPA treatment resulted in a bol esters are able to replace the endogenous activatorpartial translocation of PKC- e to both the membrane and Tri-
DAG in the stimulation of PKC has provided insight intoton-X–insoluble fractions of the cell, but total PKC- e remained
the role of PKC in the regulation of a variety of cellularessentially unchanged.
Conclusions. The present data indicate that the localization processes such as exocytosis, gene expression, prolifer-
of PKC-d and subsequent redistribution within the LLC-PK1 ation, differentiation, as well as tumor promotion [7].
cells in response to TPA treatment is highly unique and distinct
Previous studies from this laboratory have shown that
PKC activation in LLC-PK1 cells by phorbol esters causes
an increase in tight junction permeability, resulting inKey words: TPA, 12-O-tetradecanoyl phorbol 13-acetate, phosphopro-
tein, LLC-PK1 cells, isoforms of PKC, cell regulation. an enhanced paracellular flow of solutes between the
epithelial cells [8, 9]. The permeability properties of the
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physiological properties of transepithelial solute trans- tured in a-minimum essential medium without nuclo-
port across the given tissue. The dynamic nature of the sides (JRH Biosciences, Lenexa, KS, USA) supple-
tight junctional barrier is evidenced through its regula- mented with 10% fetal bovine serum (HyClone, Logan,
tion by agents as diverse as phorbol esters [10–13], cyto- UT, USA) and passaged as described previously [8].
kines [14–16], calcium [17, 18], adenosine triphosphate
Western blot analysis[19], and bacterial toxins [20]. To meet the many physio-
logical and pathological challenges to which epithelial Seven days after seeding, the differentiated cell sheets
tissues are subjected, the tight junction must be capable cultured in 75 cm2 tissue culture flasks (Falcon, Meylan,
of rapid and coordinated responses that require the pres- France) were refed with fresh culture medium plus the
ence of complex regulatory pathways. vehicle ethanol (0.01%) or with 1027 mol/L TPA and
We have shown previously that the membrane-associ- were incubated for the relevant time period. For chronic
ated fraction of PKC-a correlated with tight junction studies, cell sheets were refed on days 2 and 4 of the
permeability [8, 9, 21]. PKC-d may also play an important study. Samples taken for total PKC were washed once in
role in this permeability pathway, as cells overexpressing ice-cold phosphate-buffered saline (PBS), scraped, and
this isoform were seen to have altered permeability prop- rinsed into 2 mL of lysis buffer [150 mmol/L NaCl, 50
erties [22]. Abundant expression of PKC-d in several cell
mmol/L Tris HCl, 1 mmol/L ethylene glycol-bis [b-amino-types, including b lymphoma cells [23], myeloid cells
ethylether]-N,N,N9,N9-tetraacetic acid (EGTA), 1 mmol/L[24], fibroblasts [25, 26], neural crest-derived PC12 cells
ethylenediaminetetraacetic acid (EDTA), 1% NP-40,[27], and glioma cells [28], suggests that this isoform of
0.1% sodium deoxycholate, 0.1% sodium dodecyl sulfatePKC is of central importance in intracellular signaling.
(SDS), 20 mg/mL aprotinin, 10 mg/mL leupeptin, andAlthough the specific biological functions of PKC-d are
200 mmol/L phenylsulfonyl fluoride] at 48C. The sampleslargely unknown, this enzyme has been implicated as a
were then processed as described previously [8]. To in-regulator of cell cycling [29]. It has been shown to have
vestigate the different cell fractions, the cells wereantiproliferative actions upon overexpression in Chinese
scraped into 2 mL of buffer A (20 mmol/L Tris HCl, pHhamster ovary (CHO) [29] or NIH 3T3 cells [30, 31], and
7.5, 0.25 mol/L sucrose, 10 mmol/L EGTA, 2 mmol/Lto cause differentiation in myeloid 32D cells [32]. PKC-d
EDTA, 20 mg/mL leupeptin, 10 mg/mL aprotinin, andwas also a reasonable choice for study because in response
200 mmol/L phenylsulfonyl fluoride) at 48C and wereto TPA in polar, gastrointestinal epithelial cell sheets, it
sonicated and separated into cytosolic, membrane-asso-regulated in an opposite manner to PKC-a [33], which we
ciated (Triton-X–soluble) and fraction 3 (Triton-X–have previously shown to correlate closely with changes
in junctional permeability. PKC-d also has an obvious insoluble) fractions as described previously [8]. The pel-
association with cell adhesion [34, 35]. While PKC- e has let remaining after the third extraction was subjected to
also been shown to play a role in cell adhesion [36], this a further extraction by boiling for five minutes in 23
isoform down-regulates very similarly to PKC-a in renal sample buffer [0.0625 mol/L Tris, 2.0% SDS, 10% glyc-
epithelia [3] and, moreover, has immunolocalized to the erol, 5% mercaptoethanol, and 0.025% (wt/vol) bromo-
junctional region in gastrointestinal epithelia [37]. phenol blue]. This fraction was then called the fourth frac-
Cultured LLC-PK1 renal epithelial cells play an im- tion. SDS-polyacrylamide gel electrophoresis (PAGE)
portant role in the study of monolayer organization and was performed using 8% polyacrylamide gels on a Pro-
epithelial barrier function as well as renal function in tean II electrophoresis apparatus (Bio-Rad, Hercules,
general [38, 39]. In this work, the established LLC-PK1 CA, USA). Protein transfer to 0.45 mm nitrocellulose
renal cell line was used as a model in which phorbol (Micron Separation, Westborough, MA, USA) was per-
esters perturb epithelial barrier function through PKC formed overnight at 15 V using a Bio-Rad Transblot cell.
activation [8, 9]. The subcellular localization in LLC- After nonspecific binding was blocked with 3% bovine
PK1 epithelia of two calcium-independent PKC isoforms, serum albumin (BSA), the immunoblot was incubated
PKC-d and PKC- e , was determined in the present study with a primary mouse monoclonal anti–PKC-d antibody
in order to add to information that our group has already
(Transduction Laboratories, Lexington, KY, USA) at aobtained in this regard about PKC-a [9]. The work re-
1:500 dilution in 3% BSA for one hour at room tempera-ported here provides the first information, to our knowl-
ture. A rabbit polyclonal anti–PKC-d antibody (Santaedge, on the subcellular distribution and down-regu-
Cruz, Santa Cruz, CA, USA) was also used in this studylation of the PKC-d and PKC- e isoforms in phorbol
at a dilution of 1:100 for two hours at room temperatureester-treated LLC-PK1 epithelial cells.
after nonspecific binding was blocked with 3% milk. A
horseradish peroxidase-labeled rabbit anti-mouse IgG
METHODS secondary antibody or a goat anti-rabbit IgG secondary
Cell culture antibody was then used in conjunction with the Renais-
sance Western blot chemiluminescence kit (DuPont-LLC-PK1 cells were a gift of Dr. Robert Hull [40] and
were used between passages 184 and 202. Cells were cul- NEN, Boston, MA, USA). The labeled immunoblot was
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then placed against reflection autoradiography film (East-
man Kodak, Rochester, NY, USA) and developed in a
Kodak M35A X-OMAT processor. For PKC-e detection,
the previously mentioned immunoblot was then placed
in stripping buffer (100 mmol/L 2-mercaptoethanol, 2%
SDS, 62.5 mmol/L Tris-HCl, pH 6.7) for 30 minutes at
378C and processed as before, but now with a mouse
monoclonal anti–PKC- e antibody (Transduction Labo-
ratories) also at a 1:500 dilution.
Protein phosphatase treatment
Fifty micrograms of cell lysate from either the cytosolic
Fig. 1. Western immunoblot of protein kinase C (PKC) -d and -e in amembrane or third fraction was resuspended in 103 phos-
total cell lysate of LLC-PK1 cell sheets exposed to 1027 mol/L TPA forphatase buffer (10 mmol/L dithiothreitol, 500 mmol/L Tris up to seven days. When confluent, cells were either processed immedi-
HCl, 1 mol/L NaCl, and 1 mmol/L EDTA) containing ately, 0 minutes (lane 1), or treated with vehicle for one, four, or seven
days (lanes 2, 4, and 6, respectively), or 1027 mol/L TPA for one, four,400 U of lambda phosphatase (Recombinant, Esche-
or seven days (lanes 3, 5, and 7, respectively). Cells were refed on daysrichia coli, specific activity 300,000 U/mg protein; Calbio- 2 and 4 of the study. Each lane received 50 mg of total protein. A
chem, La Jolla, CA, USA). After incubation for 30 min- commercially available positive control (1) from rat brain lysate (Trans-
duction Laboratories) was run, and the bands observed comigrated withutes at 308C, the reaction was stopped by addition of
the 78 (d) and 90 kD (e ) bands shown here. Exclusion of the primary75 mL of 23 sample buffer. PKC-d was analyzed as antibody (mouse monoclonal from Transduction Laboratories) resulted
described previously in this article by 8% SDS-PAGE, in the disappearance of all bands (data not shown).
and then subjected to Western immunoblot with the
Santa Cruz rabbit polyclonal anti–PKC-d.
LLC-PK1 epithelial cells (Fig. 1) [41]. TPA caused aImmunofluorescence detection of PKC-d and PKC- e
nearly complete disappearance of PKC-d after one day,One 3 106 cells were seeded into Falcon 3102 filter
but by day four it reappeared in the treated cell homoge-rings. Three days after seeding, the cell sheets were refed
nate, but at much lower levels than that seen in thewith fresh medium plus the vehicle ethanol (0.01%) or
control cells. While PKC- e underwent a slight decrease
the phorbol ester TPA (1027 mol/L). For the seven-day
after TPA treatment for one day, the cell sheets from
time point, the cell sheets were refed daily. After the four and seven days did not seem to show a change in
appropriate treatment period, the cell sheets were rinsed the total levels of this isoform within the cells.
in PBS, then fixed in 3.2% paraformaldehyde for 20
minutes, rinsed again, and permeabilized in 0.1% Tri- Translocation and down-regulation of PKC-d
ton-X for three minutes. After additional rinses in PBS, and PKC- e
cell sheets were exposed to 10% normal goat serum To investigate the effect of TPA treatment on the sub-
for one hour at room temperature and then incubated cellular location of the PKC isoform, confluent LLC-PK1
overnight in either mouse monoclonal antibody to PKC-d cell monolayers, maintained in the absence or presence
(1:50), rabbit polyclonal to PKC-d (1:50), or PKC- e (1:50; of 1027 mol/L TPA for up to seven days, were then ex-
Transduction Laboratories). After rinses in PBS, cell tracted and fractionated by ultracentrifugation. Proteins
sheets were incubated with a 1:100 CY3 goat anti-mouse contained within the subcellular fractions were then ana-
secondary antibody or 1:100 CY3 goat anti-rabbit anti- lyzed by immunoblotting with isozyme-specific antibod-
body (Jackson ImmunoResearch Laboratories, West ies. In control cell populations, PKC-d was detected only
Grove, PA, USA) for one hour in the dark. After final in the cytoplasmic fraction of the cells with a monoclonal
rinses in PBS and distilled water, cell sheets were anti–PKC-d antibody (Transduction Laboratory). PKC-e ,
mounted in glycerol and viewed with epifluorescence however, while located predominantly in the cytoplasmic
illumination using rhodamine filters. fraction, was also found in the membrane-associated and
Triton-X–insoluble (cytoskeletal) fractions (Fig. 2). The
basal subcellular distribution of these two isoforms isRESULTS
therefore distinct within LLC-PK1 cells. TPA treatment
Chronic TPA treatment modulates total cellular caused PKC-d to disappear completely from the cyto-
expression of PKC-d and PKC- e plasmic fraction as early as 15 minutes after its addition
In accordance with previous reports by Amsler et al, to the cell sheet (Fig. 2). PKC-d was not detected in the
immunoblot analysis demonstrated the presence of both membrane or third fraction after treatment, indicating
that either PKC-d was not translocated in response toPKC-d and PKC-e isoforms in whole-cell homogenates of
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Fig. 2. Western immunoblot of PKC-d (A) and PKC-e (B) in cytosolic, membrane and Triton-X–insoluble fractions of LLC-PK1 cell sheets
exposed to 1027 mol/L TPA for up to 60 minutes. Confluent, differentiated cell sheets cultured in 75 cm2 tissue culture flasks were refed with
control medium for 15, 30, 45, or 60 minutes (lanes 1, 3, 5 and 7, respectively) or TPA for 15, 30, 45, or 60 minutes (lanes 2, 4, 6 and 8, respectively)
and extracted at the times indicated as described in the Methods section. Each lane received 50 mg of total protein. Exclusion of the primary
antibody resulted in the disappearance of all bands (data not shown).
TPA, was down-regulated at a faster rate than transloca- this article, a further, more stringent extraction step was
carried out with the pellet remaining after the third ex-tion, or was not recognized by this particular primary
antibody after its translocation. PKC- e was also seen to traction. This pellet, which contained the remaining
PKC-d, was Triton-X and 0.1% SDS insoluble, and wasdepart rapidly but not disappear from the cytoplasmic
fraction following the addition of TPA. It underwent a thus very likely tightly bound to the cytoskeleton. It
was able to be further extracted in the sample bufferpartial translocation to the membrane and Triton-X–
insoluble fractions where it remained elevated and mani- containing 2% SDS. PKC-d was clearly detected in this
fourth fraction at the correct molecular weight (Fig. 5).fested a second, possibly phosphoprotein, band. At later
time points, up to six hours, treatment of cells with TPA This indicates that there was a further subcellular pool
of PKC-d that was not successfully extracted by the firstresulted in a continuation of the previously mentioned
patterns of translocation and/or degradation of PKC-d three standard fractionation steps.
and PKC-e (Fig. 3). PKC-d continued to be absent from
Immunofluorescence detection of PKC-d and PKC-eall three fractions after TPA exposure, while PKC- e was
partially translocated from the cytoplasmic to the mem- Using the same antibodies to PKC-d and PKC-e as
brane and third fractions. Continuing administration of employed in the immunoblot studies, the cellular local-
TPA to cells for up to seven days resulted in PKC-d still ization of these two isoforms in the epithelia was ana-
being undetectable in the cytoplasmic, membrane and lyzed by immunofluorescence. This procedure was neces-
Triton-insoluble fractions (Fig. 4). PKC- e was now, like sary because a chronically TPA-treated cell sheet is a
PKC-d, also absent from the cytoplasmic compartment heterogeneous population of both multilayered and mo-
of the TPA-treated cells, but quite unlike PKC-d, PKC- e nolayered areas of cells [9, 21]. The Western blot tech-
remained detectable in the membrane-associated frac- niques involve homogenization of an entire cell sheet,
tion of these cells. which will average out any differences in PKC isoforms
that exist between these two cell populations. Using im-
Detection of PKC-d in a fourth fraction munofluorescence microscopy, any heterogeneity in cel-
lular distribution of PKC isoforms can be observed.As a means of explaining the persistence of PKC-d in
TPA-treated cells as seen in total cell lysates (Fig. 1) and There appeared to be a paradox between the cellular
localization of both PKC-d and PKC- e observed by West-in immunofluorescence microscopy as described later in
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Fig. 3. Western immunoblot of PKC-d (A) and - e (B) in cytosolic, membrane and Triton-X–insoluble fractions of LLC-PK1 cell sheets exposed
to 1027 mol/L TPA for up to six hours. When confluent, differentiated cell sheets cultured in 75 cm2 tissue culture flasks were either processed
immediately, 0 hour (lane 1), or were refed with control medium for two, four, or six hours (lanes 2, 4, and 6, respectively) or TPA for two, four,
or six hours (lanes 3, 5 and 7, respectively) and extracted at the times indicated as described in the Methods section. Each lane received 50 mg of
total protein. Exclusion of the primary antibody resulted in the disappearance of all bands (data not shown).
Fig. 4. Western immunoblot of PKC-d (A) and - e (B) in cytosolic, membrane and Triton-X–insoluble fractions of LLC-PK1 cell sheets exposed
to 1027 mol/L TPA for up to seven days. When confluent, differentiated cell sheets cultured in 75 cm2 tissue culture flasks were refed with control
medium for one, two, four, or seven days (lanes 1, 3, 5 and 7, respectively) or TPA for one, two, four, or seven days (lanes 2, 4, 6, and 8,
respectively). Cells were refed on days 2 and 4 of the study and extracted at the times indicated as described in the Methods section. Each lane
received 50 mg of total protein. Exclusion of the primary antibody resulted in the disappearance of all bands (data not shown).
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clonal PKC-d antibody raised against amino acids 114 to
289 of human PKC-d (Fig. 2), the control cells exhibited
PKC-d in all three cell fractions and in multiple bands
as well (Fig. 7). Treatment with TPA for one hour caused
a translocation of PKC-d from the cytosol with an in-
Fig. 5. Western immunoblot of PKC-d in a fourth fraction of control crease in its expression in both the membrane-associated
cells. The pellet remaining after the third extraction was subjected to and third fractions. Several cytoskeletal bands nearly dis-a further extraction by boiling for five minutes in 23 sample buffer and
appeared, while others exhibited marked decreases. Pro-was then called the fourth fraction. Exclusion of the primary antibody
resulted in the disappearance of all bands (data not shown). longed treatment of the cells with TPA for seven days
resulted in a substantial down-regulation of PKC-d in
both the membrane and third fraction. A third antibody
for PKC-d (Chemicon, Temecula, CA, USA), which wasern immunoblotting and immunofluorescence. This may
a sheep polyclonal antibody raised against amino acidsbe explained at least in part by the presence of substantial
128 to 142 of mouse PKC-d, did not detect any PKC-d
amounts of PKC-d and PKC- e in a fourth subcellular
in our LLC-PK1 cells (data not shown). It did, however,pool, which was not extractable in the first three cell
recognize a positive control LLC-PK1 cell line in whichfractions and only appeared after boiling and high levels
human PKC-d was overexpressed.
of SDS detergent. From Figure 6A, it can be seen that The cellular localization of PKC-d, as detected by the
in the control cell sheets, PKC-d was mainly localized anti–PKC-d rabbit polyclonal antibody, was then further
to cytoskeletal fibers with punctuated staining of the investigated by immunofluorescence. Again, unlike the
nuclei also present. Treatment of the cell monolayer with immunofluorescence profile seen using the monoclonal
TPA for one hour resulted in a more diffuse staining anti–PKC-d (Transduction), the control cells exhibited a
pattern of PKC-d throughout the cells (Fig. 6B). Seven diffuse cellular staining (Fig. 8A). One hour of treatment
days of treatment with TPA caused a pattern of localiza- with TPA (Fig. 8B) caused a movement of PKC-d to
tion that more closely resembles the control cells, with the borders of some of the cells. Treatment of the cell
PKC-d again being detected in close proximity to the monolayer with TPA for seven days (Fig. 8C) resulted
cytoskeleton. This more intense PKC-d staining at the in an overall down-regulation of PKC-d expression with
day 7 time point is due, at least in part, to increased cell a distinct staining persisting at the cell borders, a finding
number and multilayering. As seen in Figure 6C, PKC-d now in closer agreement to the Western immunoblot
levels are quite high in areas of multilayering, as was profile seen with this antibody.
demonstrated earlier for PKC-a [9]. PKC-e does not
seem to be uniformly distributed throughout the control Protein phosphatase treatment
epithelium (Fig. 6D). In cells exhibiting staining, PKC- e To investigate whether the phosphorylation state of
appears in a diffuse non-nuclear pattern. Following treat- PKC-d may be affecting antibody recognition and there-
ment with TPA for one hour, PKC- e translocated to the fore antibody binding to the antigen, the different cell
border of the cells (Fig. 6E). In contrast to the continued fractions were subjected to dephosphorylation by incu-
presence of PKC- e detected by immunoblot after seven bation with lambda phosphatase. The Western blot pro-
days of TPA treatment, low levels of this isoform were file for PKC-d was then investigated with the Santa Cruz
detected by immunofluorescence at this time point. polyclonal antibody. The less phosphorylated form of
The previously mentioned results for PKC-d were some- PKC-d (lane 1) was detected as a band that migrated
what surprising since a disappearance of this isoform slightly faster (lower arrow, Fig. 9) than the correspond-
from the cells was not observed, and yet was seen in the ing lane (lane 2) without phosphatase (upper arrow,
Western immunoblot. This apparent discrepancy be- Fig. 9). TPA treatment resulted in the appearance of
tween the immunoblot profile and the immunofluores- additional bands in the membrane-associated and third
cence data obtained using the Transduction mouse mono- fractions (lane 3). It can be seen from the TPA-treated
clonal PKC-d antibody could be partially explained by cells of both the membrane-associated and third frac-
our above finding of PKC-d in a fourth fraction, but it tions that treatment of these fractions with lambda phos-
also caused us to re-examine the expression levels of this phatase resulted in a different pattern of antibody recog-
PKC isoform with a different anti–PKC-d antibody. A nition (lane 3 compared with lane 4, Fig. 9), establishing
rabbit polyclonal anti–PKC-d antibody (Santa Cruz) di- these additional bands as phosphoproteins.
rected against the carboxy terminus of human PKC-d
was used to detect PKC-d within the cells. Surprisingly,
DISCUSSIONas shown in Figure 7, a different pattern of subcellular
localization of PKC-d was obtained using this antibody. As PKC is the major receptor for tumor-promoting
phorbol esters, it is thought that modulation of this familyUnlike the profile previously observed using the mono-
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Fig. 6. Immunofluorescence of PKC-d and
PKC- e isoforms in control, acutely and chroni-
cally TPA-treated LLC-PK1 cell sheets. (A)
PKC-d in control sheets. (B) PKC-d in cell
sheet treated for one hour with 1027 mol/L
TPA. (C) PKC-d in cell sheet treated for seven
days with 1027 mol/L TPA. (D) PKC- e in con-
trol sheets. (E) PKC- e in cell sheet treated for
one hour with 1027 mol/L TPA. (F) PKC-e in
cell sheet treated for seven days with 1027
mol/L TPA. For the seven-day time point, the
cell sheets were refed daily. After fixation,
cells were exposed to an anti–PKC-d or anti–
PKC- e monoclonal antibodies and processed
for immunofluorescence as described in the
Methods section. In controls, PKC-d was ex-
pressed predominantly in a cytoskeletal stress
fiber-like pattern, while PKC-e seemed to be
more diffusely distributed within the LLC-PK1
cells. Exposure time for PKC-d with seven-
day TPA treatment (C) was half that of A
and B because of the high intensity of staining
in this cell sheet. Exposure time for PKC-e was
the same for every panel as was the magnifica-
tion setting of all panels (bar, 25 mm).
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regulation of tight junction permeability [22]. However,
the physiological relevance of overexpressing an enzyme
within a cell is complex, since the exogenous kinase may
be expressed in areas or compartments of the cells where
the endogenous form is not found. This led us to investi-
gate further the possible role of PKC-d with the more
physiologically relevant model of activation of endoge-
nous PKC within the epithelial cell sheet by TPA. The
role of another calcium-independent isoform, PKC- e ,
in which the overexpression is oncogenic in rat colon
epithelial cells [44], was also investigated. Similar to the
atypical PKC isoforms, PKC-l and PKC-z, which colo-
calize to the cell junctional complex in the renal epithelial
Madin-Darby canine kidney (MDCK) [45] and LLC-PK1
cells [46], PKC- e has been seen to stain in the region
of the tight junction of intestinal epithelial cells [37],
suggesting a putative role in tight junctional regulation.
Our investigation of the regulation of these two PKC
isoforms by total cell lysates and Western immunoblots
revealed that TPA caused a rapid decrease in total
PKC-d content, which then returned to near control lev-
els, whereas PKC- e levels remained almost unchanged
throughout. Immunofluorescence indicated that PKC-d
had both cytosolic and cytoskeletal localization withinFig. 7. Western immunoblot of PKC-d (Santa Cruz rabbit polyclonal
antibody) in cytosolic, membrane and Triton-X–insoluble fractions of the cells, and a subtle cytoskeletal rearrangement oc-
LLC-PK1 cell sheets exposed to 1027 mol/L TPA for one hour or seven curred upon TPA treatment. Western immunoblotsdays. Confluent, differentiated cell sheets cultured in 75 cm2 tissue
showed that PKC-d did not undergo the expected mem-culture flasks were refed with control medium for zero hours, one hour,
or seven days (lanes 2, 3, and 5, respectively) or TPA for one hour or brane translocation upon activation by TPA, but merely
seven days (lanes 4 and 6, respectively). A positive control from Pd5
disappeared immediately from the cytosolic compart-cells overexpressing PKC-d was run, and the bands observed comigrated
ment. However, the observed pattern of PKC-d distribu-with the 78 kD PKC-d (lane 1). Each lane received 50 mg of total
protein. Exclusion of the primary antibody (rabbit polyclonal from tion and translocation was found to depend strongly on
Santa Cruz) resulted in the disappearance of all bands (data not shown).
the type of antibody used. This difference stems from
the apparent inability of certain antibodies to recognize
specific phosphoproteins of PKC-d.
Protein kinase C- e was localized to the cytosol, mem-of PKC isoforms is a key step in tumorigenesis. TPA
binding to PKC and resultant activation, translocation, brane, and Triton-X–insoluble fractions of the cells. TPA
treatment resulted in a partial translocation of PKC- e toand down-regulation of specific PKC isoforms is thought
to play a critical role in phorbol ester-induced cell ad- both the membrane and Triton-X–insoluble fractions of
the cell. However, it was the level of total PKC-d andhesion changes, including an increase in tight junction
leakiness followed after four days by partial recovery of not PKC- e that temporally corresponded to the recovery
of epithelial barrier function after chronic TPA treat-epithelial barrier function [42]. This study follows the
phorbol ester-induced changes in the regulation of PKC-d ment [8, 9]. PKC-d levels were markedly decreased with
24 hours of TPA treatment. However, at the later timeand PKC-e within confluent monolayers of LLC-PK1
renal epithelia. points of four and seven days, there seemed to be a
reappearance of PKC-d in the treated cells, albeit atIt has been shown previously by this group that the
level of PKC activity and the amount of membrane- lower levels than seen in the controls, a change that
would correlate somewhat with the temporal changes inassociated PKC-a temporally correlate with the TPA-
induced alterations in tight junction permeability [8, 9]. tight junction permeability [42]. Amsler et al noted an
increase in PKC-d levels after chronic TPA treatmentIt was also shown that overexpression of PKC-a in con-
junction with phorbol ester exposure induced transepi- in LLC-PK1 cells, but reported barely detectable levels
in control cells [41]. This discrepancy in levels of PKC-dthelial leakiness and eventual cell detachment [43]. More
recently, it has been shown that overexpression of PKC-d detected in that study and those reported here may be
due to the different PKC extraction procedures used inalso causes increased tight junction permeability in LLC-
PK1 epithelia. This occurs even in the absence of phorbol the two studies. There seemed to be a slight decrease in
PKC- e levels after one day of TPA treatment, but at theesters, suggesting a possible role for this isoform in the
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Fig. 8. Immunofluorescence of PKC-d isoforms in control, acutely and chronically TPA-treated LLC-PK1 cell sheets. (A) PKC-d in control sheets.
(B) PKC-d in a cell sheet treated for one hour with 1027 mol/L TPA. (C) PKC-d in a cell sheet treated for seven days with 1027 mol/L TPA. For
the seven-day time point, the cell sheets were refed daily. After fixation, cells were exposed to an anti–PKC-d polyclonal antibody (Santa Cruz)
and processed for immunofluorescence, as described in the Methods section. In controls (A), PKC-d exhibited a diffuse cellular staining, while
treatment with TPA for one hour (B) resulted in the movement of PKC-d to the cell borders. Seven-day treatment with TPA (C) resulted in an
overall down-regulation of PKC-d. Exposure time was the same for every panel, as was the magnification setting of all panels (bar, 25 mm).
initial decrease in Rt but not the later recovery. These
present data thus suggest that PKC-d, but not PKC- e ,
may play a role in the regulation of LLC-PK1 epithelial
barrier function.
A general model for the regulation of PKC activity
often includes translocation (tight association) of PKC
to the membrane in response to activator binding, ac-
companied by a conformational change of the enzyme
within the lipid environment of the membrane that re-
sults in a catalytically active PKC [5]. This is often fol-
lowed by a rapid inactivation, apparently because of a
decrease in activator binding of PKC from the membrane
complex. However, in this present study, the usual pat-
tern of redistribution of PKC to the membrane fraction
followed by down-regulation does not seem to hold true
for PKC-d based on results with the monoclonal antibody
Fig. 9. Western immunoblot of PKC-d (Santa Cruz rabbit polyclonal to PKC-d (Transduction). Treatment of cells with TPA
antibody) in cytosolic, membrane and Triton-X–insoluble fractions of appeared to result in a rapid disappearance of PKC-dLLC-PK1 cell sheets exposed to 1027 mol/L TPA for one hour and
from the cytoplasmic compartment without reappear-incubated in the presence or absence of lambda phosphatase. Confluent,
differentiated cell sheets cultured in 75 cm2 tissue culture flasks were ance in the membrane or Triton-X–insoluble fractions.
refed with control medium (Lanes 1 and 2) or TPA (lanes 3 and 4) for In T84 human epithelial cells, TPA was observed to causeone hour and extracted as described in the Methods section. Fifty
persistent translocation of PKC-d to the membrane com-micrograms of protein were incubated with lambda phosphatase
(400 U) for 30 minutes at 308C. Each lane received 50 mg of total partment, but also caused a 400% increase in PKC-d
protein. Exclusion of the primary antibody (rabbit polyclonal from
mRNA after 24 hours [33]. Our lack of detected PKC-dSanta Cruz) resulted in the disappearance of all bands (data not shown).
in the membrane-associated fraction of the LLC-PK1
cells in the present study was first thought not to be an
antibody recognition problem, as treatment of the cells
later time points, there did not appear to be a significant with another known PKC activator, bryostatin-1, did re-
effect of TPA on this isoform’s total level of expression sult in the detection of PKC-d in the membrane-associ-
within the cells. In addition to total PKC-d levels seen ated compartment by 10 minutes using the same primary
in Western immunoblots, the TPA-induced cytoskeletal antibody (unpublished results). From the immunofluo-
rearrangement of PKC-d seen in immunofluorescence rescence results it would seem that the majority of the
also correlated with the complete transepithelial resis- PKC-d isoform associates tightly with a cytoskeletal frac-
tance (Rt) profile, unlike the partial translocation of tion within these cells, which was inextractable by the
conditions normally used for Western immunoblot anal-PKC-e seen in immunoblots, which correlated with the
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ysis. To investigate this more fully, the pellet remaining PK1 cells. Although we have temporally correlated the
changes in amount and localization of PKC-d, but notafter the third fraction (Methods section) was subjected
to a further extraction in 2% SDS followed by boiling, PKC- e , with the previously observed changes in paracel-
lular permeability, it is difficult to prove an etiological re-and the obtained sample was analyzed by Western immu-
noblot. A further pool of PKC-d was identified that may lationship. If PKC-d is, in fact, playing a role in the phorbol
ester-induced changes in LLC-PK1 epithelial barrier func-belong to a very tightly associated cytoskeleton fraction
(Fig. 5). It is interesting to note, however, that in the total tion, it would seem to be doing so in a different subcellular
compartment than PKC-a. Unlike PKC-a, PKC-d is acell lysates, a reappearance of PKC-d was observed at
days 4 and 7, while in the subcellular localization studies, calcium-insensitive isoform of PKC and might be ex-
pected to have a distinct subcellular distribution in thesePKC-d did not reappear in the cytosol, the fraction from
where it originally disappeared. epithelial cells. Unlike the diffuse localization of PKC-a
in LLC-PK1 cells [9], the colocalization of PKC-d withThis unexpected disappearance of PKC-d from the cyto-
sol without apparent translocation to the membrane the cytoskeleton detected with the mouse monoclonal
anti–PKC-d would indicate that this isoform may modu-compartment of the cell was further investigated by using
a second antibody directed to a different epitope of late epithelial permeability through phosphorylation of
a target protein localized to the cytoskeleton or the cy-PKC-d. Surprisingly, as in Figure 7, a different expression
pattern of PKC-d within the cell compartments was ob- toskeleton itself. This compartmental model with differ-
ent target proteins gains credibility from studies donetained for this isoform of PKC. PKC-d was now detected
in all three fractions of the control cells with a TPA- with PKC-a and PKC-d overexpressing LLC-PK1 cells
[22]. The cells overexpressing PKC-a required TPA toinduced translocation of this isoform from the cytosolic
fraction to the membrane-associated and third fractions induce gross morphological changes and a decrease in
Rt, while cells with high levels of the PKC-d isoformafter one hour.
Protein kinase C-d has been shown to be phosphory- were constitutively leaky along the paracellular pathway.
This indicates that exogenously expressed PKC-d inlated in many different cell types on phorbol ester activa-
tion [47, 48]. A possible explanation for the different these cells may be located in a DAG-rich compartment,
PKC-d binding patterns, which we observed with the two resulting in a basally activated form of this isozyme.
different PKC-d antibodies, may be that different antibod- A secondary but important methodological finding of
ies to PKC-d recognize different phosphorylated forms this study is that the Western immunoblot data obtained
of the protein. This was investigated by incubation of from a single specific antibody to a PKC isoform may re-
the different cell fractions of both control and TPA- veal only part of the profile of translocation and down-
treated cell extracts with a lambda phosphatase. The less regulation of the isoform. We believe that this is so be-
phosphorylated form of PKC-d was observed as a slightly cause the two different anti–PKC-d antibodies used in
faster migrating PKC-d band, which was about 2 kD our studies appeared to recognize different PKC-d phos-
smaller than the corresponding PKC-d band from a cell phoproteins. This explanation seems reasonable because
extract, which had not been incubated with the phospha- (1) PKC-d activation is known to result in changes in
tase. It can be seen clearly from the cell fractions in lanes the PKC-d phosphorylation state [47]; (2) phorbol ester
3 and 4 of Figure 9 that at least partial dephosphorylation exposure resulted in shifts in the apparent molecular
of PKC-d by lambda phosphatase resulted in a greater weight of PKC-d bands when using one but not the other
number of PKC-d bands becoming visible when using antibody in our studies; (3) the use of lambda phospha-
the Santa Cruz polyclonal antibody. This antibody may tase shows these different bands to be phosphoproteins;
be able to recognize the less phosphorylated forms of and (4) our two antibodies have distinct antigenic recog-
PKC-d because of a slightly different conformational state nition sites on PKC-d. One should therefore be aware
of the protein and/or the phosphorylation state of the of the possibility that any treatment capable of increasing
recognition site. Phosphorylation of PKC-d may mask the phosphorylation state of a PKC isoform may cause a
the antigenic binding site of the monoclonal antibody false “disappearance” of one or more bands in a Western
(Transduction Labs) and prevent detection of PKC-d, immunoblot, depending on the antibody used. The im-
thus explaining the different subcellular localization pat- portance of the LLC-PK1 cell line as a model for study
terns obtained. This finding has been reported previously of renal apoptosis [50, 51] and of PKC-d in the regulation
where two different PKC-m antibodies were able to se- of apoptosis [52, 53] makes our observations here on
lectively detect nonphosphorylated or phosphorylated PKC-d in LLC-PK1 epithelia particularly pertinent.
forms of this PKC isoform [49]. Therefore, such proper-
ties of an antibody should be carefully studied before ACKNOWLEDGMENTS
being used to quantitatively determine protein levels.
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